Asia-Pacific Psychedelic Drugs Market to 2032
Overview
The Asia-Pacific Psychedelic Drugs Market is expected to reach a 107.62 USD Billion by 2032 and is projected to grow at a CAGR of 14.62% from 2025 to 2032.
Revenue, 2024 (USD Billion)
45.78
Forecast, 2032 (USD Billion)
107.62
CAGR, 2024 - 2032
14.62%
Report Coverage
Asia-Pacific
Asia-Pacific Psychedelic Drugs Market 2018-2032 USD Billion
Asia-Pacific Psychedelic Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 45.78 USD Billion
- Projected Market Size (2032): 107.62 USD Billion
- CAGR (2025-2032): 14.62%
Key Findings of Asia-Pacific Psychedelic Drugs Market
- The Asia-Pacific Psychedelic Drugs Market was valued at 45.78 USD Billion in 2024.
- The Asia-Pacific Psychedelic Drugs Market is likely to grow at a CAGR of 14.62% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Synthetic in Source Segment accounted for the largest share of the market with a revenue of 45.78 USD Billion
- The fastest growing segment Post-Traumatic Stress Disorder in Application Segment grew Fastest with a CAGR of 19.03% during the forecast period from 2024 to 2032.
Asia-Pacific Psychedelic Drugs Market Scope
Asia-Pacific Psychedelic Drugs Market Segmentation & Scope
End User
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hopitals Pharmacy
- Retail Pharmacy
- Online Pharmacy
Route of Administration
- Injectable
- Inhalation
- Oral
Source
- Synthetic
- Natural
Type
- Empathogens
- Dissociatives
- Others
Drugs
- Gamma-Hydroxybutyric Acid
- Psilocybin
- Others
- Ketamine
Application
- Narcolepsy
- Treatment Resistant Depression
- Major Depressive Disorder
- Opiate Addiction
- Post-Traumatic Stress Disorder
- Others
Asia-Pacific Psychedelic Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 45.78 USD Billion |
| Market Value in 2032 | 107.62 USD Billion |
| CAGR (2025-2032) | 14.62% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Route of Administration,Source,Type,Drugs,Application |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 45.78 USD Billion in 2024
- Key Country: India, leading in terms of revenue with value of 15.53 USD Billion in 2024.
Segments and Scope
-
Asia-Pacific Psychedelic Drugs Market to 2032, By End User
- Hospitals is the largest segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a revenue of 26.11 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a Growth rate of 15.38 % in forecast period 2025-2032.
-
Asia-Pacific Psychedelic Drugs Market to 2032, By Distribution Channel
- Online Pharmacy is the largest segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a revenue of 30.00 USD Billion in the year 2024.
- Online Pharmacy is the Fastest growing segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a Growth rate of 15.18 % in forecast period 2025-2032.
-
Asia-Pacific Psychedelic Drugs Market to 2032, By Route of Administration
- Inhalation is the largest segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a revenue of 23.33 USD Billion in the year 2024.
- Oral is the Fastest growing segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a Growth rate of 12.97 % in forecast period 2025-2032.
-
Asia-Pacific Psychedelic Drugs Market to 2032, By Source
- Synthetic is the largest segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a revenue of 45.78 USD Billion in the year 2024.
- Synthetic is the Fastest growing segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a Growth rate of 14.62 % in forecast period 2025-2032.
-
Asia-Pacific Psychedelic Drugs Market to 2032, By Type
- Dissociatives is the largest segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a revenue of 24.38 USD Billion in the year 2024.
- Empathogens is the Fastest growing segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a Growth rate of 13.45 % in forecast period 2025-2032.
-
Asia-Pacific Psychedelic Drugs Market to 2032, By Drugs
- Ketamine is the largest segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a revenue of 23.87 USD Billion in the year 2024.
- Gamma-Hydroxybutyric Acid is the Fastest growing segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a Growth rate of 13.80 % in forecast period 2025-2032.
-
Asia-Pacific Psychedelic Drugs Market to 2032, By Application
- Narcolepsy is the largest segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a revenue of 17.08 USD Billion in the year 2024.
- Post-Traumatic Stress Disorder is the Fastest growing segment in Asia-Pacific Psychedelic Drugs Market to 2032 with a Growth rate of 14.80 % in forecast period 2025-2032.
Asia-Pacific Psychedelic Drugs Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| Jazz Pharmaceuticals, Inc. | |||
| Janssen Global Services, LLC | |||
| ICU Medical, Inc. | |||
| Stryker | |||
Asia-Pacific Psychedelic Drugs Market Geographical Sales Distribution, 2018-2032 USD Billion
Asia-Pacific Psychedelic Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Psychedelic Drugs Market is segmented based on Segmentation End User,Distribution Channel,Route of Administration,Source,Type,Drugs,Application.
Asia-Pacific Psychedelic Drugs Market was valued at USD 45.78(Revenue in USD Billion) in 2022.
Asia-Pacific Psychedelic Drugs Market is projected to grow at a CAGR of 14.62% during the forecast period of 2024 to 2032.
The Synthetic segment is expected to dominate the Asia-Pacific Psychedelic Drugs Market, holding a largest market share of 45.78 USD Billion in 2024
Asia-Pacific Psychedelic Drugs Market Scope
Asia-Pacific Psychedelic Drugs Market Segmentation & Scope
End User
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hopitals Pharmacy
- Retail Pharmacy
- Online Pharmacy
Route of Administration
- Injectable
- Inhalation
- Oral
Source
- Synthetic
- Natural
Type
- Empathogens
- Dissociatives
- Others
Drugs
- Gamma-Hydroxybutyric Acid
- Psilocybin
- Others
- Ketamine
Application
- Narcolepsy
- Treatment Resistant Depression
- Major Depressive Disorder
- Opiate Addiction
- Post-Traumatic Stress Disorder
- Others
Frequently Asked Questions
The Asia-Pacific Psychedelic Drugs Market is segmented based on Segmentation End User,Distribution Channel,Route of Administration,Source,Type,Drugs,Application.
Asia-Pacific Psychedelic Drugs Market was valued at USD 45.78(Revenue in USD Billion) in 2022.
Asia-Pacific Psychedelic Drugs Market is projected to grow at a CAGR of 14.62% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Psychedelic Drugs Market for final year is USD 107.62 (USD Billion).
Asia-Pacific Psychedelic Drugs Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Psychedelic Drugs Market is segmented based on Segmentation End User,Distribution Channel,Route of Administration,Source,Type,Drugs,Application.
Asia-Pacific Psychedelic Drugs Market was valued at USD 45.78(Revenue in USD Billion) in 2022.
Asia-Pacific Psychedelic Drugs Market is projected to grow at a CAGR of 14.62% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Psychedelic Drugs Market for final year is USD 107.62 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.